LEI NIE to Class I Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications LEI NIE has written about Class I Phosphatidylinositol 3-Kinases.
Connection Strength
0.105
-
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma. Clin Cancer Res. 2015 Apr 01; 21(7):1525-9.
Score: 0.105
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.